Back

Prognostic impact of the tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure ratio in acute pulmonary embolism

31 August 2024 (18:00 - 18:50)
Organised by: Logo
Congress Presentation Part of: New physical insights into pulmonary vascular disease Pulmonary Embolism (PE) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Barkin Kultursay

Tunceli State Hospital, Tunceli (Turkiye)

6 More presentations in this session

Presentation thumbnail
Echocardiographic insights redefining risk in pulmonary arterial hypertension: a focus on right atrial volume index for enhanced stratification
Doctor L. Brochado (Almada, PT)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of the Aria pulmonary endovascular device in pulmonary hypertension
Associate Professor C. Gerges (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
May right heart failure cause pulmonary congestion in pulmonary arterial hypertension?
Professor M. D'Alto (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension
Mr M. Andersen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Echocaridographic assessment of pulmonary hypertension: improving the probability
Mr C. Wild (Bath, GB)
Abstract Slides Video

Access the full session

Session thumbnail
New physical insights into pulmonary vascular disease

The Event

Event poster

ESC Congress 2024

31 August 2024 18:00 CET
You may be interested in
thumbnail
Congress Presentation
TAPSE/PASP ratio: revealing the hidden predictor of pulmonary hypertension in acute pulmonary embolism
thumbnail
Congress Presentation
Prognostic value of the echocardiographic ratio tricuspid annular plane systolic excursion / pulmonary arterial systolic pressure in acute pulmonary embolism
thumbnail
Congress Presentation
TAPSE/sPAP ratio predicts 1-Year mortality in cardiac resynchronization therapy recipients with heart failure background

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources